Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Otorhinolaryngology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    May 2020
  1. SEIWERT TY, Kochanny S, Wood K, Worden FP, et al
    A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
    Cancer. 2020 May 4. doi: 10.1002/cncr.32929.
    PubMed     Abstract available


    March 2020
  2. CHEN FP, Huang XD, Lv JW, Wen DW, et al
    Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32770.
    PubMed     Abstract available


    February 2020
  3. MROZ EA, Patel KB, Rocco JW
    Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
    Cancer. 2020 Feb 21. doi: 10.1002/cncr.32742.
    PubMed     Abstract available


  4. KOCHANNY SE, Worden FP, Adkins DR, Lim DW, et al
    A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Cancer. 2020 Feb 19. doi: 10.1002/cncr.32762.
    PubMed     Abstract available


  5. BASAK SK, Bera A, Yoon AJ, Morselli M, et al
    A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32644.
    PubMed     Abstract available


    January 2020
  6. KHAN A, Mubdi N, Budnick A, Feldman DR, et al
    The experience of hearing loss in adult survivors of childhood and young adult cancer: A qualitative study.
    Cancer. 2020 Jan 3. doi: 10.1002/cncr.32698.
    PubMed     Abstract available


    December 2019
  7. DZIEGIELEWSKI PT, McNeely ML, Ashworth N, O'Connell DA, et al
    2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial.
    Cancer. 2019 Dec 24. doi: 10.1002/cncr.32681.
    PubMed     Abstract available


  8. CHEN YY, Wang CC, Wu WT, Lai CH, et al
    Trajectories of returning to work and its impact on survival in survivors with oral cancer: A 5-year follow-up study.
    Cancer. 2019 Dec 6. doi: 10.1002/cncr.32643.
    PubMed     Abstract available


    November 2019
  9. NG SP, Ajayi T, Schaefer AJ, Pollard C 3rd, et al
    Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.
    Cancer. 2019 Nov 14. doi: 10.1002/cncr.32597.
    PubMed     Abstract available


  10. THOMPSON-HARVEY A, Yetukuri M, Hansen AR, Simpson MC, et al
    Rising incidence of late-stage head and neck cancer in the United States.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32583.
    PubMed     Abstract available


  11. KAWAKITA D, Abdelaziz S, Chen Y, Rowe K, et al
    Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32617.
    PubMed     Abstract available


  12. LIU C, Guo T, Sakai A, Ren S, et al
    A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32610.
    PubMed     Abstract available


    October 2019
  13. NOCON CC, Ajmani GS, Bhayani MK
    A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.
    Cancer. 2019 Oct 3. doi: 10.1002/cncr.32342.
    PubMed     Abstract available


    September 2019
  14. LIN C, Cao SM, Chang ET, Liu Z, et al
    Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study.
    Cancer. 2019 Sep 22. doi: 10.1002/cncr.32458.
    PubMed     Abstract available


  15. ARGIRION I, Zarins KR, Ruterbusch JJ, Vatanasapt P, et al
    Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
    Cancer. 2019 Sep 16. doi: 10.1002/cncr.32517.
    PubMed     Abstract available


    August 2019
  16. AMENABAR JM, Torres-Pereira CC, Tang KD, Punyadeera C, et al
    Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    Cancer. 2019 Aug 7. doi: 10.1002/cncr.32435.
    PubMed     Abstract available


    July 2019
  17. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    PubMed     Abstract available


  18. SASAKI CT, Doukas SG, Costa J, Vageli DP, et al
    Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32369.
    PubMed     Abstract available


    June 2019
  19. HADDAD R, Concha-Benavente F, Blumenschein G Jr, Fayette J, et al
    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190.
    PubMed     Abstract available


  20. KIM M, Kim BH, Kim JM, Kim EH, et al
    Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Cancer. 2019 Jun 19. doi: 10.1002/cncr.32166.
    PubMed     Abstract available


  21. PATEL SA, Qureshi MM, Dyer MA, Jalisi S, et al
    Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32292.
    PubMed     Abstract available


    May 2019
  22. PATIL VM, Noronha V, Joshi A, Agarwal J, et al
    A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Cancer. 2019 May 31. doi: 10.1002/cncr.32179.
    PubMed     Abstract available


  23. PARK A, Alabaster A, Shen H, Mell LK, et al
    Undertreatment of women with locoregionally advanced head and neck cancer.
    Cancer. 2019 May 15. doi: 10.1002/cncr.32187.
    PubMed     Abstract available


  24. GRANT S, Kamal M, Mohamed ASR, Zaveri J, et al
    Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    Cancer. 2019;125:1654-1664.
    PubMed     Abstract available


  25. LIN TA, Garden AS, Elhalawani H, Elgohari B, et al
    Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Cancer. 2019;125:1536-1546.
    PubMed     Abstract available


    April 2019
  26. ROLLO F, Pichi B, Benevolo M, Giuliani M, et al
    Oral testing for high-risk human papillomavirus DNA and E6/E7 messenger RNA in healthy individuals at risk for oral infection.
    Cancer. 2019 Apr 29. doi: 10.1002/cncr.32152.
    PubMed     Abstract available


  27. TIAN S, Switchenko JM, Jhaveri J, Cassidy RJ, et al
    Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32115.
    PubMed     Abstract available


    March 2019
  28. FAKHRY C, Zhang Q, Gillison ML, Nguyen-Tan PF, et al
    Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
    Cancer. 2019 Mar 26. doi: 10.1002/cncr.32025.
    PubMed     Abstract available


  29. BEITLER JJ, Switchenko JM, Dignam JJ, McDonald MW, et al
    Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx.
    Cancer. 2019;125:704-711.
    PubMed     Abstract available


  30. FARAJI F, Rettig EM, Tsai HL, El Asmar M, et al
    The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Cancer. 2019;125:761-769.
    PubMed     Abstract available


    February 2019
  31. NG SP, Pollard C 3rd, Berends J, Ayoub Z, et al
    Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.31983.
    PubMed     Abstract available


  32. LEE NCJ, Kelly JR, An Y, Park HS, et al
    Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32001.
    PubMed     Abstract available


    January 2019
  33. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.
    PubMed    


  34. WINDON MJ, D'Souza G, Faraji F, Troy T, et al
    Priorities, concerns, and regret among patients with head and neck cancer.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31920.
    PubMed     Abstract available


  35. LIU APY, Hastings C, Wu S, Bass JK, et al
    Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31918.
    PubMed     Abstract available


  36. BEESLEY LJ, Hawkins PG, Amlani LM, Bellile EL, et al
    Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.
    Cancer. 2019;125:68-78.
    PubMed     Abstract available


    December 2018
  37. JIANG C, Wang H, Xia C, Dong Q, et al
    A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31907.
    PubMed     Abstract available


  38. BADR H, Herbert K, Chhabria K, Sandulache VC, et al
    Self-management intervention for head and neck cancer couples: Results of a randomized pilot trial.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31906.
    PubMed     Abstract available


    November 2018
  39. CRACCHIOLO JR, Klassen AF, Young-Afat DA, Albornoz CR, et al
    Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q head and neck cancer module.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31900.
    PubMed     Abstract available


  40. EYTAN DF, Blackford AL, Eisele DW, Fakhry C, et al
    Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
    Cancer. 2018 Nov 16. doi: 10.1002/cncr.31800.
    PubMed     Abstract available


  41. GREALLY M, Ilson DH
    Neoadjuvant therapy for esophageal cancer: Who, when, and what?
    Cancer. 2018;124:4276-4278.
    PubMed    


    October 2018
  42. HARADA K, Pool Pizzi M, Baba H, Shanbhag ND, et al
    Cancer stem cells in esophageal cancer and response to therapy.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31697.
    PubMed    


  43. GUO R, Tang LL, Mao YP, Du XJ, et al
    Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31741.
    PubMed     Abstract available


  44. THAM T
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31819.
    PubMed    


  45. CHAN JYW, Huang WB, Liu DL
    Reply to Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31815.
    PubMed    


  46. BAUML JM, Vinnakota R, Anna Park YH, Bates SE, et al
    Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data.
    Cancer. 2018 Oct 20. doi: 10.1002/cncr.31816.
    PubMed     Abstract available


  47. XIANG M, Holsinger FC, Colevas AD, Chen MM, et al
    Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31708.
    PubMed     Abstract available


  48. BAUMAN JE, Duvvuri U, Thomas S, Gooding WE, et al
    Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31651.
    PubMed     Abstract available


  49. SABA NF, Mendenhall WM, Hutcheson K, Suarez C, et al
    Salvage Surgery for Squamous Cell Carcinoma of the Head and Neck in the Era of Immunotherapy: Is It Time to Clarify Our Guidelines?
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31717.
    PubMed    


    August 2018
  50. SARAFIM-SILVA BAM, Duarte GD, Sundefeld MLMM, Biasoli ER, et al
    Childhood Trauma Is Predictive for Clinical Staging, Alcohol Consumption, and Emotional Symptoms in Patients With Head and Neck Cancer.
    Cancer. 2018 Aug 6. doi: 10.1002/cncr.31597.
    PubMed     Abstract available


    June 2018
  51. GRABOYES EM, Ellis MA, Li H, Kaczmar JM, et al
    Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31571.
    PubMed     Abstract available


    May 2018
  52. SOTO-PEREZ-DE-CELIS E, Sun CL, Tew WP, Mohile SG, et al
    Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31540.
    PubMed     Abstract available


  53. XIAO C, Beitler JJ, Higgins KA, Glazer T, et al
    Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31537.
    PubMed     Abstract available


  54. HO AS, Kim S, Tighiouart M, Mita A, et al
    Quantitative survival impact of composite treatment delays in head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31533.
    PubMed     Abstract available


  55. WEISS JM, Grilley-Olson JE, Deal AM, Zevallos JP, et al
    Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31526.
    PubMed     Abstract available


    April 2018
  56. GUERRIERO MK, Redman MW, Baker KK, Martins RG, et al
    Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31407.
    PubMed     Abstract available


  57. TOTA JE, Engels EA, Madeleine MM, Clarke CA, et al
    Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31359.
    PubMed     Abstract available


    March 2018
  58. HU J, Bao C, Gao J, Guan X, et al
    Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31318.
    PubMed     Abstract available


    January 2018
  59. ZIMMARO LA, Sephton SE, Siwik CJ, Phillips KM, et al
    Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Cancer. 2018 Jan 22. doi: 10.1002/cncr.31109.
    PubMed     Abstract available


  60. XIAO R, Ward MC, Yang K, Adelstein DJ, et al
    Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31213.
    PubMed     Abstract available


  61. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Abstract available


    December 2017
  62. DAHLSTROM KR, Anderson KS, Field MS, Chowell D, et al
    Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Cancer. 2017;123:4886-4894.
    PubMed     Abstract available


  63. CHIN RI, Rao YJ, Hwang MY, Spencer CR, et al
    Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
    Cancer. 2017;123:4594-4607.
    PubMed     Abstract available


    November 2017
  64. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.
    PubMed    


  65. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.
    PubMed    


  66. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Abstract available


  67. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.
    PubMed    


  68. LANG KUHS KA, Kreimer AR, Trivedi S, Holzinger D, et al
    Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer. 2017;123:4382-4390.
    PubMed     Abstract available


  69. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Abstract available


  70. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Abstract available


    October 2017
  71. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Abstract available


  72. BURTNESS B
    The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31059.
    PubMed    


  73. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    PubMed     Abstract available


  74. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Abstract available


  75. CAPARROTTI F, Huang SH, Lu L, Bratman SV, et al
    Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Cancer. 2017;123:3691-3700.
    PubMed     Abstract available


    September 2017
  76. SACCO AG, Cohen EE
    Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30970.
    PubMed    


    August 2017
  77. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Abstract available


  78. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Abstract available


    April 2017
  79. D'SOUZA G, Robbins HA
    Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.
    Cancer. 2017;123:1092-1094.
    PubMed    


    March 2017
  80. SINHA P, Haughey BH, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharyngeal carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:887-888.
    PubMed    


    January 2017
  81. COOPER JS, Fortpied C, Gregoire V, Le QT, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:12-16.
    PubMed    


  82. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.
    PubMed    


  83. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: